Fertility

Titus Health Care contributes through sister company ARTPred to the development and marketing of a Fertility Microbiome Profiling test (ReceptIVFity). This test can provide insight for women with fertility problems when an IVF treatment will not help them become pregnant.

ReceptIVFity

Sister company ARTPred in collaboration with Erasmus MC in Rotterdam and the Free University of Amsterdam, has conducted a new fertility test (ReceptIVFity) developed. The ReceptIVFity test gives women with fertility problems insight into the chances in IVF or ICSI based on the microbiome profile.
This test was validated in eight Dutch IVF clinics during the 'ReceptIVFity-I study'. The ReceptIVFity-test is CE-IVD certified. ReceptIVFity is not yet reimbursed, but is already available in a select number of IVF clinics (Erasmus Medisch Centrum Rotterdam and Elisabeth Ziekenhuis Tilburg). All information about this test can be found at www.receptivfity.com.

ReceptIVFity